[{"@id":"\/content\/generalized_news\/eb8ec65d-67e8-445b-90d5-f817b0eaf5c8","@type":"GeneralizedNews","id":"eb8ec65d-67e8-445b-90d5-f817b0eaf5c8","typeKey":"us_news","newsDate":"2022-09-29T20:41:00+00:00","newsDateOffset":-14400,"headline":{"en":"SAFEGUARD SCIENTIFICS ANNOUNCES LUMESIS EXIT"},"subheadline":[],"summary":{"en":"\nRADNOR, Pa., Sept. 29, 2022 (GLOBE NEWSWIRE) -- Safeguard Scientifics, Inc. (NYSE:SFE) (\u201cSafeguard\u201d) today announced the acquisition of Lumesis by SOLVE Advisors, Inc., a market data platform for fixed income securities. Safeguard received $5.3 million of initial cash proceeds. Additional cash proceeds may be received from the final determinations of net working capital and the resolution of ..."},"category":[],"tags":[],"attachments":[],"css":"","metaData":[],"urls":[],"disclaimer":null,"newsDateLocal":"2022-09-29 16:41:00"},{"@id":"\/content\/generalized_news\/801a8c23-3aa0-423e-9446-935280c9be94","@type":"GeneralizedNews","id":"801a8c23-3aa0-423e-9446-935280c9be94","typeKey":"us_news","newsDate":"2022-09-27T11:33:00+00:00","newsDateOffset":-14400,"headline":{"en":"Aktana Welcomes New Medical Affairs Lead from IBM Watson Health (Now Merative)"},"subheadline":[],"summary":{"en":"\nDeepak Patil brings deep data science experience in life sciences to drive Aktana\u2019s medical affairs team in response to growing need for improved healthcare professional engagement SAN FRANCISCO--(BUSINESS WIRE)-- Aktana, the leader in intelligent customer engagement for the global life sciences industry, welcomes Deepak Patil as its new senior director of medical strategy. Patil comes to ..."},"category":[],"tags":[],"attachments":[],"css":".bwalignc { text-align: center; list-style-position: inside }","metaData":[],"urls":[],"disclaimer":null,"newsDateLocal":"2022-09-27 07:33:00"},{"@id":"\/content\/generalized_news\/e7cf5a0c-0d66-4f5b-9a78-670d0767aea2","@type":"GeneralizedNews","id":"e7cf5a0c-0d66-4f5b-9a78-670d0767aea2","typeKey":"us_news","newsDate":"2022-09-27T11:33:00+00:00","newsDateOffset":-14400,"headline":{"en":"Aktana and Envision Pharma Group Partner to Help Medical Affairs Navigate the Evolving Physician Engagement Landscape"},"subheadline":[],"summary":{"en":"\nHCP demands for more responsive, coordinated engagement across the life sciences organization are driving MSLs to adopt a more agile and value-driven omnichannel approach SAN FRANCISCO & LONDON--(BUSINESS WIRE)-- Aktana, the leader in intelligent customer engagement for the life sciences industry, and Envision Pharma Group, a global, technology-enabled scientific communications company ..."},"category":[],"tags":[],"attachments":[],"css":".bwalignc { text-align: center; list-style-position: inside }","metaData":[],"urls":[],"disclaimer":null,"newsDateLocal":"2022-09-27 07:33:00"},{"@id":"\/content\/generalized_news\/c50c8fd8-b462-41e1-aabe-8d8194ad4b76","@type":"GeneralizedNews","id":"c50c8fd8-b462-41e1-aabe-8d8194ad4b76","typeKey":"us_news","newsDate":"2022-09-15T12:00:00+00:00","newsDateOffset":-14400,"headline":{"en":"Syapse Enters Collaboration with Merck Using Real-World Evidence to Better Understand Cancers"},"subheadline":[],"summary":{"en":"\nSAN FRANCISCO and NEW YORK, Sept. 15, 2022 (GLOBE NEWSWIRE) -- Syapse®, a leading real-world evidence company dedicated to extinguishing the fear and burden of serious diseases by advancing real-world care, has entered a collaboration with Merck, known as MSD, outside the United States and Canada, to leverage Syapse\u2019s leading real-world evidence solutions designed to improve outcomes for ..."},"category":[],"tags":[],"attachments":[],"css":"","metaData":[],"urls":[],"disclaimer":null,"newsDateLocal":"2022-09-15 08:00:00"},{"@id":"\/content\/generalized_news\/f5ed7fd5-19ca-4859-abd5-5564ba6a811b","@type":"GeneralizedNews","id":"f5ed7fd5-19ca-4859-abd5-5564ba6a811b","typeKey":"us_news","newsDate":"2022-09-13T12:57:00+00:00","newsDateOffset":-14400,"headline":{"en":"Remote and Hybrid Workers Have Higher Degree of Psychological Safety at Work Than On-site Employees, Says New meQuilibrium Study"},"subheadline":[],"summary":{"en":"\nReluctance to return is more than just the commute BOSTON, Sept. 13, 2022 \/PRNewswire\/ -- Remote employees have enjoyed better work-life balance, no commute, and the ability to work anywhere, however, a new meQuilibrium survey of 3,900 employees sheds new light on why people are reluctant to return to office -- remote and hybrid employees have a higher degree of psychological safety at work ..."},"category":[],"tags":[],"attachments":[],"css":"\/* Style Definitions *\/\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}","metaData":[],"urls":[],"disclaimer":null,"newsDateLocal":"2022-09-13 08:57:00"},{"@id":"\/content\/generalized_news\/2206cc1d-d6f2-4f74-8817-3a6f78b718e7","@type":"GeneralizedNews","id":"2206cc1d-d6f2-4f74-8817-3a6f78b718e7","typeKey":"us_news","newsDate":"2022-09-08T12:43:00+00:00","newsDateOffset":-14400,"headline":{"en":"Earvin \"Magic\" Johnson to Keynote meQuilibrium's Resilience 2022 Conference Sept. 29-30"},"subheadline":[],"summary":{"en":"\nHR Leaders and Wellbeing Experts from US Roche Genentech, Paychex, JP Morgan Chase & Co to discuss how to build a culture of resilience BOSTON, Sept. 8, 2022 \/PRNewswire\/ -- Improving workforce wellbeing and performance will be the focus of meQuilibrium's third annual Resilience conference, being held virtually September 29-30. NBA legend, philanthropist, and entrepreneur Earvin \"Magic\" ..."},"category":[],"tags":[],"attachments":[],"css":"\/* Style Definitions *\/\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n .prntal{\nTEXT-ALIGN: LEFT\n}","metaData":[],"urls":[],"disclaimer":null,"newsDateLocal":"2022-09-08 08:43:00"},{"@id":"\/content\/generalized_news\/64de8ac1-5ded-4018-9c4b-29752847c076","@type":"GeneralizedNews","id":"64de8ac1-5ded-4018-9c4b-29752847c076","typeKey":"us_news","newsDate":"2022-08-31T12:00:00+00:00","newsDateOffset":-14400,"headline":{"en":"Syapse and Genesis Research Combine Forces to Offer Real-World Evidence Services and Data to Oncology Innovators"},"subheadline":[],"summary":{"en":"\nSAN FRANCISCO, Aug. 31, 2022 (GLOBE NEWSWIRE) -- Syapse®, a leading real-world evidence company dedicated to extinguishing the fear and burden of serious diseases by advancing real-world care, today announced that they have entered into a strategic partnership with Genesis Research, combining the expertise and resources of both companies to better serve clients developing new oncology ..."},"category":[],"tags":[],"attachments":[],"css":"","metaData":[],"urls":[],"disclaimer":null,"newsDateLocal":"2022-08-31 08:00:00"},{"@id":"\/content\/generalized_news\/27c50c95-fab3-4208-a2ee-51de5b302dae","@type":"GeneralizedNews","id":"27c50c95-fab3-4208-a2ee-51de5b302dae","typeKey":"us_news","newsDate":"2022-08-11T20:15:00+00:00","newsDateOffset":-14400,"headline":{"en":"Safeguard Scientifics Announces Second Quarter 2022 Financial Results"},"subheadline":[],"summary":{"en":"\nRADNOR, Pa., Aug. 11, 2022 (GLOBE NEWSWIRE) -- Safeguard Scientifics, Inc. (NYSE:SFE) (\u201cSafeguard\u201d or the \u201cCompany\u201d) today announced financial results for the three and six months ended June 30, 2022. SECOND QUARTER 2022 HIGHLIGHTS Safeguard Company Performance Moxe raised $30 million in an equity round to further support its strong growth and expand its clinical data exchange solutions. The ..."},"category":[],"tags":[],"attachments":[],"css":"","metaData":[],"urls":[],"disclaimer":null,"newsDateLocal":"2022-08-11 16:15:00"},{"@id":"\/content\/generalized_news\/06bf862f-23c2-46ff-bae3-f04092d48ff4","@type":"GeneralizedNews","id":"06bf862f-23c2-46ff-bae3-f04092d48ff4","typeKey":"us_news","newsDate":"2022-08-02T20:30:00+00:00","newsDateOffset":-14400,"headline":{"en":"SAFEGUARD SCIENTIFICS TO RELEASE SECOND QUARTER 2022\u00a0FINANCIAL RESULTS ON THURSDAY, AUGUST 11th"},"subheadline":[],"summary":{"en":"\nRADNOR, Pa., Aug. 02, 2022 (GLOBE NEWSWIRE) -- Safeguard Scientifics, Inc. (NYSE:SFE) will release its financial results for the second quarter ended June 30, 2022 after the market close on Thursday, August 11, 2022. CONFERENCE CALL AND WEBCAST DETAILS Please call 10-15 minutes prior to the call to register. Date: Thursday, August 11, 2022 Time: 5:00 pm ET Live Number: 877-407-0989 Webcast ..."},"category":[],"tags":[],"attachments":[],"css":"","metaData":[],"urls":[],"disclaimer":null,"newsDateLocal":"2022-08-02 16:30:00"},{"@id":"\/content\/generalized_news\/a4504446-d870-43a8-879c-cc4e9553fc76","@type":"GeneralizedNews","id":"a4504446-d870-43a8-879c-cc4e9553fc76","typeKey":"us_news","newsDate":"2022-07-21T13:00:00+00:00","newsDateOffset":-14400,"headline":{"en":"MediaMath Announces Two Executive-Level Hires"},"subheadline":[],"summary":{"en":"\nNew additions to leadership team will build upon sales and client services, data & analytics, and partnerships NEW YORK, July 21, 2022 \/PRNewswire\/ -- MediaMath, the leading global independent demand-side platform, announces two new appointments to its leadership team, Sylvain Le Borgne as its Chief Partnership Officer and Head of Data & Analytics and Andy Ellenthal as Executive Vice President ..."},"category":[],"tags":[],"attachments":[],"css":"\/* Style Definitions *\/\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}","metaData":[],"urls":[],"disclaimer":null,"newsDateLocal":"2022-07-21 09:00:00"},{"@id":"\/content\/generalized_news\/fb219bd6-09ec-4fdb-93d7-6691fc76337f","@type":"GeneralizedNews","id":"fb219bd6-09ec-4fdb-93d7-6691fc76337f","typeKey":"custom_news","newsDate":"2022-06-23T14:36:00+00:00","newsDateOffset":0,"headline":{"en":"meQuilibrium Appoints Experience Design Expert Dustin DiTommaso as Chief Design Officer"},"subheadline":{"en":""},"summary":{"en":""},"category":[],"tags":[],"attachments":[{"@type":"GeneralizedNewsAttachment","@id":"_:2969","url":"\/media\/custom-news\/e6349c70-73e2-4d8e-bdb4-e2d371c1a3f2\/assets\/3e509c5f-20fe-4778-b08d-f06588fe564c\/meQuilibrium Appoints Experience Design Expert Dustin DiTommaso as Chief Design Officer.pdf","fileName":"meQuilibrium Appoints Experience Design Expert Dustin DiTommaso as Chief Design Officer.pdf","fileType":"application\/pdf","thumbnails":[]}],"css":null,"metaData":{"en":[]},"urls":{"en":[]},"disclaimer":null,"newsDateLocal":"2022-06-23 10:36:00"},{"@id":"\/content\/generalized_news\/413c05e0-3fc4-4b52-95ed-ce290e03e652","@type":"GeneralizedNews","id":"413c05e0-3fc4-4b52-95ed-ce290e03e652","typeKey":"us_news","newsDate":"2022-06-14T14:00:00+00:00","newsDateOffset":-14400,"headline":{"en":"Syapse and Pierian Announce Genomics Collaboration to Power Precision Oncology"},"subheadline":[],"summary":{"en":"\nSAN FRANCISCO, June 14, 2022 (GLOBE NEWSWIRE) -- Syapse®, a leading real-world evidence company announced with Pierian®, a global leader in advanced clinical genomics technology, a new joint collaboration that will benefit patients of the AdventHealth Cancer Institute in Central Florida. The collaboration combines Syapse\u2019s real-world evidence solutions designed to improve outcomes for patients ..."},"category":[],"tags":[],"attachments":[],"css":"","metaData":[],"urls":[],"disclaimer":null,"newsDateLocal":"2022-06-14 10:00:00"},{"@id":"\/content\/generalized_news\/5ad04b8b-15c2-40b9-a5d4-0795d3d5079f","@type":"GeneralizedNews","id":"5ad04b8b-15c2-40b9-a5d4-0795d3d5079f","typeKey":"custom_news","newsDate":"2022-06-01T20:05:00+00:00","newsDateOffset":0,"headline":{"en":"Moxe Health Raises $30M Series B to Further Advance Interoperability"},"subheadline":{"en":""},"summary":{"en":""},"category":[],"tags":[],"attachments":[{"@type":"GeneralizedNewsAttachment","@id":"_:3000","url":"\/media\/custom-news\/9857fc9a-b488-4e56-8aeb-e595e6bc411b\/assets\/e28881e9-eabd-422e-baad-a6953555807e\/Moxe Health Raises $30M Series B to Further Advance Interoperability.pdf","fileName":"Moxe Health Raises $30M Series B to Further Advance Interoperability.pdf","fileType":"application\/pdf","thumbnails":[]}],"css":null,"metaData":{"en":[]},"urls":{"en":[]},"disclaimer":null,"newsDateLocal":"2022-06-01 16:05:00"},{"@id":"\/content\/generalized_news\/9cd989fc-436c-4b1a-a77b-2dcbc6ad92ad","@type":"GeneralizedNews","id":"9cd989fc-436c-4b1a-a77b-2dcbc6ad92ad","typeKey":"us_news","newsDate":"2022-05-27T14:00:00+00:00","newsDateOffset":-14400,"headline":{"en":"Syapse Unveils Two New Studies on Use of Machine Learning on Real-World Data to Identify and Treat Cancer With Precision at ASCO 2022"},"subheadline":[],"summary":{"en":"\nSAN FRANCISCO, May 27, 2022 (GLOBE NEWSWIRE) -- Syapse®, a leading real-world evidence company dedicated to extinguishing the fear and burden of serious diseases by advancing real-world care, today announced two new studies focused on how the use of machine learning on real-world data can be used to power precision medicine solutions. Syapse will be presenting at the American Society for ..."},"category":[],"tags":[],"attachments":[],"css":"","metaData":[],"urls":[],"disclaimer":null,"newsDateLocal":"2022-05-27 10:00:00"},{"@id":"\/content\/generalized_news\/4c8c1004-8d23-41ba-a5a0-65ec530d9f7a","@type":"GeneralizedNews","id":"4c8c1004-8d23-41ba-a5a0-65ec530d9f7a","typeKey":"us_news","newsDate":"2022-05-26T11:07:00+00:00","newsDateOffset":-14400,"headline":{"en":"Prognos Health Enhances HCP Precision Marketing Suite with Planning Engine to Accelerate RWD Insights and Improve Health Outcomes"},"subheadline":[],"summary":{"en":"\nPharma marketers now have easy access to identify patient populations with precision and plan before they acquire the right RWD to integrate into their HCP omnichannel disease awareness campaigns. NEW YORK--(BUSINESS WIRE)-- Real world data marketplace and analytics platform leader, Prognos Health, today announced the launch of their real world data planning engine to help pharmaceutical ..."},"category":[],"tags":[],"attachments":[],"css":"","metaData":[],"urls":[],"disclaimer":null,"newsDateLocal":"2022-05-26 07:07:00"},{"@id":"\/content\/generalized_news\/33b3c4ac-f948-44f6-a4dd-a86bdbed16c2","@type":"GeneralizedNews","id":"33b3c4ac-f948-44f6-a4dd-a86bdbed16c2","typeKey":"us_news","newsDate":"2022-05-05T20:15:00+00:00","newsDateOffset":-14400,"headline":{"en":"Safeguard Scientifics Announces First Quarter 2022 Financial Results"},"subheadline":[],"summary":{"en":"RADNOR, Pa., May 05, 2022 (GLOBE NEWSWIRE) -- Safeguard Scientifics, Inc. (NYSE:SFE) (\u201cSafeguard\u201d or the \u201cCompany\u201d) today announced financial results for the three months ended March 31, 2022. FIRST QUARTER 2022 HIGHLIGHTS Capital Return Safeguard repurchased 147,795 shares on the open market at an average price of $5.27 per share, totaling $0.8 million.Safeguard has repurchased $0.4 million ..."},"category":[],"tags":[],"attachments":[],"css":"","metaData":[],"urls":[],"disclaimer":null,"newsDateLocal":"2022-05-05 16:15:00"},{"@id":"\/content\/generalized_news\/4c968da8-354f-4d38-a6f3-a1298eb319c9","@type":"GeneralizedNews","id":"4c968da8-354f-4d38-a6f3-a1298eb319c9","typeKey":"us_news","newsDate":"2022-05-04T11:55:00+00:00","newsDateOffset":-14400,"headline":{"en":"Almirall Deploys Aktana's Contextual Intelligence 360 to Optimize Customer Engagement"},"subheadline":[],"summary":{"en":"Almirall, LLC achieves 86% user engagement and a dramatic rise in field rep productivity SAN FRANCISCO--(BUSINESS WIRE)-- Aktana, the leader in intelligent customer engagement for the global life sciences industry, announced that Almirall, LLC selected its Contextual Intelligence Engine for nationwide rollout across two leading brands in the United States. The global skin health leader ..."},"category":[],"tags":[],"attachments":[],"css":".bwalignc { text-align: center; list-style-position: inside }","metaData":[],"urls":[],"disclaimer":null,"newsDateLocal":"2022-05-04 07:55:00"},{"@id":"\/content\/generalized_news\/4b75d0d7-541b-4891-9844-2c02863f8d17","@type":"GeneralizedNews","id":"4b75d0d7-541b-4891-9844-2c02863f8d17","typeKey":"us_news","newsDate":"2022-04-25T12:00:00+00:00","newsDateOffset":-14400,"headline":{"en":"SAFEGUARD SCIENTIFICS TO RELEASE FIRST QUARTER 2022 FINANCIAL RESULTS ON THURSDAY, MAY 5th"},"subheadline":[],"summary":{"en":"\nRADNOR, Pa., April 25, 2022 (GLOBE NEWSWIRE) -- Safeguard Scientifics, Inc. (NYSE:SFE) will release its financial results for the first quarter ended March 31, 2022 after the market close on Thursday, May 5, 2022. CONFERENCE CALL AND WEBCAST DETAILS Please call 10-15 minutes prior to the call to register. Date: Thursday, May 5, 2022 Time: 5:00 pm ET Live Number: 888-482-7458 Webcast link: ..."},"category":[],"tags":[],"attachments":[],"css":"","metaData":[],"urls":[],"disclaimer":null,"newsDateLocal":"2022-04-25 08:00:00"},{"@id":"\/content\/generalized_news\/ac323f0d-7808-41dd-a320-de8a978279b8","@type":"GeneralizedNews","id":"ac323f0d-7808-41dd-a320-de8a978279b8","typeKey":"us_news","newsDate":"2022-04-21T14:00:00+00:00","newsDateOffset":-14400,"headline":{"en":"MediaMath Executes Recapitalization Transaction, Strengthening Platform for the Future"},"subheadline":[],"summary":{"en":"\nNEW YORK, April 21, 2022 \/PRNewswire\/ -- MediaMath has consummated a comprehensive recapitalization transaction whereby certain existing shareholders and financial stakeholders, including funds advised by Searchlight Capital Partners, L.P. (\"Searchlight\"), have committed to invest up to $150 million into the business through a mix of new capital and a refinancing of existing debt. In concert ..."},"category":[],"tags":[],"attachments":[],"css":"\/* Style Definitions *\/\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}","metaData":[],"urls":[],"disclaimer":null,"newsDateLocal":"2022-04-21 10:00:00"},{"@id":"\/content\/generalized_news\/484c3a83-e858-4da5-970b-c952e80d7b6f","@type":"GeneralizedNews","id":"484c3a83-e858-4da5-970b-c952e80d7b6f","typeKey":"us_news","newsDate":"2022-03-31T14:00:00+00:00","newsDateOffset":-14400,"headline":{"en":"Syapse Announces Changes to Board of Directors, Adding Michael Mentesana and Elevating Frank Williams to Chairman Role"},"subheadline":[],"summary":{"en":"SAN FRANCISCO, March 31, 2022 (GLOBE NEWSWIRE) -- Syapse®, a leading real-world evidence company dedicated to extinguishing the fear and burden of serious diseases by advancing real-world care, today announced that long-time board member and health industry veteran Frank Williams has been named as Chairman of the company\u2019s board of directors. Additionally, the company announced that it has ..."},"category":[],"tags":[],"attachments":[],"css":"","metaData":[],"urls":[],"disclaimer":null,"newsDateLocal":"2022-03-31 10:00:00"}]